|Articles|March 10, 2023
- Pharmaceutical Executive: March 2023
- Volume 43
- Issue 3
Pharmaceutical Executive, March 2023 Issue (PDF)
Advertisement
Articles in this issue
over 3 years ago
Navigating Disruption in the Metapharma Eraover 3 years ago
Biopharma M&A: Year in Review, Ripples Aheadover 3 years ago
Balancing Pharma Hiring Practices in Good Times and Badover 3 years ago
Being KOL-Centric: More Meaningful Expert Engagementover 3 years ago
Food for Thought: Make Room for Multiple Opinionsover 3 years ago
The Pivot to Digitalover 3 years ago
More than Ever, Data Will Dictate Future Fortunesover 3 years ago
Generative AI’s Breakthrough Potential in Pharma Marketingover 3 years ago
The Challenge of Taking on Falsified Medicines in EuropeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
2
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
3
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
4
When Drug Pricing Becomes Trade Policy
5

